Alternative tests: Carcinogenesis as an example

Environmental Health Perspectives

Volumn 106, Issue SUPPL. 2, 1998, Pages 467-471

  Schwetz, Bernard ^a   Gaylor, David ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Alternative tests; Carcinogenesis; Regulations

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; CARCINOGEN TESTING; CARCINOGENESIS; CONFERENCE PAPER; DECISION MAKING; DOSE RESPONSE; GENETICS; MOUSE; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; TOXICITY;

ANIMALIA;

EID: 0031804435     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.98106467     Document Type: Conference Paper

References (20)

1. U.S. Food and Drug Administration. International Conference on Harmonization: draft guideline on testing for carcinogenicity of pharmaceuticals. Fed Reg 61(163):43298-43300 (1996).
2. Ames BN, Magaw R, Gold LS. Ranking possible carcinogenic hazards. Science 236:271-280 (1987).
3. Haseman JK, Rao GN. Effects of corn oil, time-related changes, and interlaboratory variability in tumor occurrence in control Fischer 344 (F344/N) rats. Toxicol Pathol 20:52-60 (1992).
4. Seilkop SK. The effect of body weight on tumor incidence and carcinogenicity testing in B6C3F1 mice and F344 rats. Fundam Appl Toxicol 24:247-259 (1995).
5. DiCarlo FJ. Carcinogenesis bioassay data: correlation by species and sex. Drug Metab Rev 15:409-413 (1984).
6. Huff J, Cirvello J, Haseman JK, Bucher J. Chemicals associated with site-specific neoplasia in 1394 long-term carcinogenesis experiments in laboratory rodents. Environ Health Perspect 93:247-270 (1991).
7. Contrera JF, Jacobs AC, DeGeorge JJ. Carcinogenicity testing and the evaluation of regulatory requirements for pharmaceuticals. Regul Toxicol Pharmacol 25:130-145 (1997).
8. Crouch E, Wilson R. Interspecies comparison of carcinogenic potency. J Toxicol Environ Health 5:1095-1118 (1979).
9. Crouch EAC. Uncertainties in interspecies extrapolations of carcinogenicity. Environ Health Perspect 50:321-328 (1983).
10. Gold LS, de Veciana M, Backman GM, Magaw R, Lopipero P, Smith M, Blumenthal M, Levinson R, Gerson J, Bernstein L et al. Chronological supplement to the Carcinogenic Potency Database: standardized results of animal bioassays published through December 1982. Environ Health Perspect 67:161-200 (1986).
11. Gaylor DW, Chen JJ. Relative potency of chemical carcinogens in rodents. Risk Anal 6:283-290 (1986).
12. Chen JJ, Gaylor DW. Carcinogenic risk assessment: comparison of estimated safe doses for rats and mice. Environ Health Perspect 72:305-309 (1987).
13. Tennant RW, Spalding J, Staisiewicz S, Ashby J. Prediction of the outcome of rodent carcinogenicity bioassays currently being conducted on 44 chemicals by the National Toxicology Program. Mutagenesis 5:3-14 (1990).
14. Wachsman JT, Bristol DW, Spalding J, Shelby J, Tennant, RW. Predicting chemical carcinogenesis in rodents. Environ Health Perspect 101:444-445 (1993).
15. Ashby J, Tennant RW. Prediction of rodent carcinogenicity for 44 chemicals: results. Mutagenesis 9:7-15 (1994).
16. Haseman JK. Statistical issues in the design, analysis and interpretation of animal carcinogenicity studies. Environ Health Perspect 58:385-392 (1984).
17. Ashby J, Purchase IFH. Will all chemicals be carcinogenic to rodents when adequately evaluated? Carcinogenesis 8:489-495 (1993).
18. Haseman JK. A reexamination of false-positive rates for carcinogenesis studies. Fundam Appl Toxicol 3:334-339 (1983).
19. Gaylor DWG. Unpublished data.
20. International Life Sciences Institute. ILSI HESI mobilizes rapid response to need for data on alternative approaches in carcinogenicity testing. ILSI News 14(5):3 (1996).